Open Call for Patient Input – Joint Assessment on a Medicinal Product for UC.
EUnetHTA recently started a new Joint Assessment on a medicinal product for the treatment of adult patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response with. lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contraindications to such therapies. To find out […]
Open Call for Patient Input – Joint Assessment on a Medicinal Product for DBLCL.
EUnetHTA recently started a new Joint Assessment on a medicinal product for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for hematopoietic stem cell transplant. To find out more about how patient input can contribute to this assessment, please read further here. Input is greatly appreciated […]
The Collaborative Assessment, OTCA12, on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)” is now available.
The Collaborative Assessment, OTCA12, on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)” is now available. We are pleased to announce that the collaborative rapid assessment on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute […]
OTCA16 Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease) Final Assessment Now Available.
We are pleased to announce that the collaborative rapid assessment, OTCA16, on “BIORESORBABLE STENTS FOR THE TREATMENT OF CARDIOVASCULAR INDICATIONS (CORONARY ARTERY DISEASE)” is now available. The health technology assessed is a device for percutaneous coronary intervention (PCI). The objective of this assessment was to evaluate the relative effectiveness and safety of this technology in […]
OCTA20 “Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)” final project plan now available.
The final project plan of the assessment OTCA20 on “Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)” and the comments provided by external experts and the manufacturer are now available. OTCA20 Final Project Plan HERE OTCA20 External Expert & Manufacturer Comments HERE
The Collaborative Assessment, OTCA06, on “Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk” is now available
We are pleased to announce that the collaborative rapid assessment, OTCA06, on “TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) FOR THE TREATMENT OF PATIENTS AT INTERMEDIATE SURGICAL RISK” is available. The health technology assessed is a bioprothesis in the aortic valve deployed using a catheter. The objective of this assessment was to evaluate the relative effectiveness and […]
OTCA19 “Screening for osteoporosis in the general population” project plan now available
The final project plan of the assessment OTCA19 on “Screening for osteoporosis in the general population” and the comments provided by external experts are now available. OTCA19 Project Plan HERE OTCA19 External Expert Comments HERE
Implementation Report Now Available: National Uptake and Case Studies
Implementation Report – November 2018 Appendix: Case study on joint REA to inform economic evaluation – interview summaries Find all implementation reports HERE Find statistical graphics and usage maps HERE
Public consultation on medicinal product for relapsed or refractory Acute Myeloid Leukaemia (AML)
OTCA11 Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery project plan now available.
We are pleased to announce that the collaborative rapid assessment, OTCA11, on :“Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcomes in patients undergoing knee, maxillofacial, or cranial surgery” is now available. This rapid assessment addresses the research question whether 3D printed custom-made or […]
